We are pleased to announce that Oliver Gramlich, Ph.D., will present a seminar as part of the North Texas Research Institute (NTERI) Interdisciplinary Seminar Series (ISS) entitled ” Advancements and Drawbacks in Preclinical Optic Neuropathy Treatments: From Mesenchymal Stem Cells to Small Molecule Drugs “.
Date: Thursday, September 26th, 2024
Time: 12:30 pm – 1:30 pm
Location: IREB 260
Dr. Gramlich’s research focuses on optic nerve degeneration, a critical aspect of optic neuropathies such as glaucoma and multiple sclerosis. His work investigates the neuroinflammatory processes that drive the degeneration of retinal ganglion cells and oligodendrocytes. By utilizing human donor tissue, animal models, and in vitro systems, Dr. Gramlich aims to develop advanced stem-cell and drug-based therapies to restore vision and enhance clinical outcomes. His current projects explore the role of complement system activation and metabolic pathways in safeguarding retinal ganglion cells in glaucoma and facilitating myelin repair in MS, with the goal of improving visual acuity and nerve signal transmission.
We encourage you to attend in person. However, if you are unable to join us in person, a Zoom option is available below:
https://unthsc.zoom.us/j/89680760799, Meeting ID: 896 8076 0799
For more information, click here: